Abstract:BACKGROUND: Noninvasive prenatal screening (NIPS) using plasma cell-free DNA has gained tremendous popularity in the clinical assessment of fetal aneuploidy. Most, if not all, of these tests rely on complex and expensive massively parallel sequencing (MPS) techniques, hindering the use of NIPS as a common screening procedure. METHODS: We have developed and optimized an MPS independent noninvasive genetic test that can rapidly detect fetal aneuploidy at considerably lower costs. We used the high-throughput ligation-dependent probe amplification (HLPA) assay with standard z score statistics to identify the minute copy number change of targeted chromosomal regions. HLPA was modified from multiplex ligation-dependent probe amplification to allow quantification of up to 200 genomic loci in a single multiplex PCR. As a proof of principle, we conducted Down syndrome screening in 1182 women with singleton pregnancies [maternal age (SD): 32.7 (4.6)] using whole-genome sequencing-based NIPS and our method. RESULTS: Nineteen fetuses with trisomy 21 were detected by both methods and confirmed by karyotyping of amniotic fluid. Overall, our method showed 100.0% sensitivity (19/19) and 99.7% specificity (1076/1079) in trisomy 21 screening, generating a positive predictive value of 86.4% (19/22) and a 7.1% (84/1182) no-call rate. CONCLUSIONS: Our technique potentially opens new avenues for the development of inexpensive, yet effective, prenatal aneuploidy tests. The simplicity and accuracy of this method make it a good candidate for clinical implementation as a standard screening procedure. (C) 2016 American Association for Clinical Chemistry

Rapid detection of 18-trisomy syndrome using primed in situ labeling technique

[Rapid Detection of Chromosomes X and Y Using Dual-Color Primed in Situ Labeling Technique].

Rapid Detection of Chromosome 18 Aneuploidies in Amniocytes by Using Primed in Situ Labeling (PRINS) Technique

The use of the primed in situ labeling technique in the diagnosis of 21-trisomy syndrome

Rapid Prenatal Diagnosis of Fetal Chromosomal Aneuploidies 18 by Primed in situ Labeling

[Use of the Primed in Situ Labeling Technique for a Rapid Detection of Chromosomes X, 18].

Molecular Cytogenetic Detection of Trisomy 21 in Interphase Nuclei and Metaphase Chromosomes.

Noninvasive Prenatal Screening of Fetal Aneuploidy without Massively Parallel Sequencing

Clinical application of noninvasive prenatal testing for the detection of trisomies 21, 18, and 13: a hospital experience.

Rapid Detection of Chromosomal Aneuploidies by Multiplex Ligation-Dependent Probe Amplification

A Quality Assurance Scheme for Prenatal Detection of Aneuploidy Based on Developing Chimeric Quality-Control Cells

Rapid diagnosis of aneuploidy in chromosomes 13, 18, 21, X and Y by quantitative fluorescence-PCR combined with short tandem repeat and fluorescence-labeled homologous gene quantitative‑PCR using 4-color fluorescently labeled universal primers.

Study on rapid genetic diagnosis of trisomy 21

Prenatal diagnosis for chromosome aneuploidies in 50 amniotic fluid samples with fluorescence in situ hybridization

Noninvasive prenatal diagnosis of trisomy 21 using analysis of short tandem repeats

Rapid Prenatal Diagnosis of Down Syndrome by Quantitative Fluorescence Polymerase Chain Reaction

Prenatal Diagnosis of Common Chromosomal Aneuploidies by Fluorescence in Situ Hybridization

A research and application of multiplex ligation-dependent probe amplification(MLPA) in rapid prenatal detection of fetal chromosomes aneuploid abnormalities.

Rapid Prenatal Diagnosis of Chromosome Aneuploidies In60 Uncultured Amniotic Fluid Samples by Fluorescence in Situ Hybridization

A Novel Diagnostic Strategy for Trisomy 21 Using Short Tandem Repeats.

Prenatal Diagnosis of Common Chromosomal Aneuploidies on Uncultured Amniotic Fluid Cells by Fluorescence in Situ Hybridization